BioAge Hosting Webcast to Discuss Newly Announced Phase 1b Data Demonstrating BGE-105 Significantly

Experts and company leadership to discuss clinical significance of indications driven by muscle atrophy and Ph2 trial design for acute ICU myopathies in older patientsRICHMOND, Calif.--(BUSINESS WIRE)--#aging--BioAge Labs, Inc. (“BioAge”), a clinical-stage biotechnology company developing therapeutics that target th...

Related Keywords

Toronto ,Ontario ,Canada ,Peng Leong ,William Evans ,Kols Williamj Evans ,Andreessen Horowitz ,Ewan Goligher ,Chris Patil ,University Of Toronto ,University Health Network ,Medicine Geriatrics At Duke University ,Bioage Labs Inc ,Senate Select Committee On ,Health Division At Kinemed ,Kaiser Foundation Hospitals ,Bioage Labs ,Adjunct Professor ,Human Nutrition ,Health Division ,Muscle Metabolism Discovery Performance ,Senate Select Committee ,Caffeinated Capital ,Khosla Ventures ,Daniel Ferry ,